Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].

David Sánchez-López, David García-Vega, J E Viñuela, Isabel Ferreirós-Vidal, Diego Iglesias-Álvarez, José Manuel Martínez-Cereijo, Laura Reija-López, Ángel L Fernández-González, José R González-Juanatey, Sonia Eiras